ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO847

Albuminuria and Vascular Health in Females with CKD

Session Information

Category: Women's Health and Kidney Diseases

  • 2200 Women's Health and Kidney Diseases

Authors

  • Pattar, Badal S.B., University of Calgary, Calgary, Alberta, Canada
  • Larsen, Nicole, University of Calgary, Calgary, Alberta, Canada
  • Ahmed, Sofia B., University of Calgary, Calgary, Alberta, Canada
  • Holodinsky, Jessalyn K., University of Calgary, Calgary, Alberta, Canada
  • Kharbanda, Sakshi, University of Calgary, Calgary, Alberta, Canada
  • Rabi, Sarah M., University of Calgary, Calgary, Alberta, Canada
  • Sola, Darlene Y., University of Calgary, Calgary, Alberta, Canada
  • Dumanski, Sandi M., University of Calgary, Calgary, Alberta, Canada
Background

Cardiovascular (CV) disease is the leading cause of death in chronic kidney disease (CKD), and elevated CV risk occurs earlier in the CKD disease course in females compared to males. Albuminuria, a marker of CKD severity, has been independently associated with CV disease in females, however the mechanism of this association is not yet understood. This study aimed to determine the association between albuminuria and markers of vascular health, including mean arterial pressure (MAP) and arterial stiffness, as measured by aortic augmentation index (AIx) and pulse-wave velocity (PWV), in females with CKD.

Methods

An exploratory cross-sectional study recruited 54 females with CKD from nephrology clinics in Calgary, Alberta. Albuminuria was quantified by collection of a midstream urine and measurement of urine albumin-to-creatine ratio (ACR). Using standardized protocols, blood pressure and arterial stiffness were measured. Multiple linear regression analysis was used to estimate the association between urine ACR and each marker of vascular health.

Results

Albuminuria was significantly associated with MAP (R2 = 0.20; p = 0.001) and AIx (R2 = 0.21; p = 0.006), but was not associated with PWV (R2 = 0.11; p = 0.127).

Conclusion

Disruptions in vascular health, specifically related to elevated blood pressure and increased peripheral wave reflection, may represent the pathophysiologic mechanism by which albuminuria is associated with increased CV risk in females with CKD. These risk factors may represent modifiable risk factors that serve as treatment targets for CV risk reduction in this important population.

Funding

  • Government Support – Non-U.S.